Nicholas Valiante is the Co-Founder and Chief Scientific Officer at Innovac Therapeutics, where they focus on developing new vaccine paradigms. With a Ph.D. in Immunology from the University of Pennsylvania, Nicholas has held significant positions in various prominent organizations, including serving as Global Head of Immunology and Immunotherapy at Novartis Vaccines and leading R&D for Personalized mRNA Cancer Vaccines at Moderna Therapeutics. Their career spans decades, beginning with a research internship at DuPont in 1987 and continuing through leadership roles in immunology and vaccine development across several renowned institutions.
Location
Cambridge, United States